NCT05965557View on ClinicalTrials.gov

Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung Cancer
Trial Locations (1)

Unknown

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Geneplus-Beijing Co. Ltd.

INDUSTRY